Th1 Cells Alter the Inflammatory Signature of IL-6 by Channeling STAT Transcription Factors to Alu-like Retroelements

Cytokines that signal via STAT1 and STAT3 transcription factors instruct decisions affecting tissue homeostasis, anti-microbial host defense, and inflammation-induced tissue injury. To understand the coordination of these activities, we applied RNA-seq, ChIP-seq, and ATAC-seq to identify the transcriptional output of STAT1 and STAT3 in peritoneal tissues during acute resolving inflammation and inflammation primed to drive fibrosis. Bioinformatics focussed on the transcriptional signature of the immuno-modulatory cytokine IL-6 in both settings and examined how pro-fibrotic IFNγ-secreting CD4+ T-cells altered the interpretation of STAT1 and STAT3 cytokine cues. In resolving inflammation, STAT1 and STAT3 cooperated to drive stromal gene expression affecting anti-microbial immunity and tissue homeostasis. The introduction of IFNγ-secreting CD4+ T-cells altered this transcriptional program and channeled STAT1 and STAT3 to a previously latent GAS motif in Alu-like elements. STAT1 and STAT3 binding to this conserved sequence revealed evidence of reciprocal cross-regulation and gene signatures relevant to pathophysiology. Thus, we propose that effector T-cells re-tune the transcriptional output of IL-6 by shaping a regulatory interplay between STAT1 and STAT3 in inflammation.

[1]  G. Lythe,et al.  Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses , 2021, bioRxiv.

[2]  Christoph Bock,et al.  Structural cells are key regulators of organ-specific immune response , 2020, Nature.

[3]  D. Mole,et al.  Stromal Cells Covering Omental Fat-Associated Lymphoid Clusters Trigger Formation of Neutrophil Aggregates to Capture Peritoneal Contaminants , 2020, Immunity.

[4]  M. Kazemian,et al.  CDK8 Fine-Tunes IL-6 Transcriptional Activities by Limiting STAT3 Resident Time at the Gene Loci , 2020, bioRxiv.

[5]  Xiaohua Shen,et al.  Genomic Repeats Categorize Genes with Distinct Functions for Orchestrated Regulation , 2020, Cell reports.

[6]  William J. Astle,et al.  The Polygenic and Monogenic Basis of Blood Traits and Diseases , 2020, Cell.

[7]  Zan-zhe Yu,et al.  IL-6 Trans-signaling Drives a STAT3-dependent Pathway That Leads to Structural Alterations of Peritoneal Membrane. , 2019, American journal of physiology. Renal physiology.

[8]  Simon A. Jones,et al.  T-Cell–Specific PTPN2 Deficiency in NOD Mice Accelerates the Development of Type 1 Diabetes and Autoimmune Comorbidities , 2019, Diabetes.

[9]  W. Leonard,et al.  Fine-Tuning Cytokine Signals. , 2019, Annual review of immunology.

[10]  A. Freeman,et al.  STAT1 and STAT3 mutations: important lessons for clinical immunologists , 2018, Expert review of clinical immunology.

[11]  Simon A. Jones,et al.  Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer , 2018, Nature Reviews Immunology.

[12]  H. Kong,et al.  Human defects in STAT3 promote oral mucosal fungal and bacterial dysbiosis. , 2018, JCI insight.

[13]  J. Calva-Mercado,et al.  Recurrent Spontaneous Intestinal Perforation due to STAT1 GOF Mutation , 2018, American Journal of Gastroenterology.

[14]  Nicholas A. Sinnott-Armstrong,et al.  An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues , 2017, Nature Methods.

[15]  Ling-Ling Chen,et al.  ALUternative Regulation for Gene Expression. , 2017, Trends in cell biology.

[16]  Jef D. Boeke,et al.  Structural variants caused by Alu insertions are associated with risks for many human diseases , 2017, Proceedings of the National Academy of Sciences.

[17]  C. Fielding,et al.  IL-6 Trans-Signaling Links Inflammation with Angiogenesis in the Peritoneal Membrane. , 2017, Journal of the American Society of Nephrology : JASN.

[18]  Yuka Kanno,et al.  Mechanisms and consequences of Jak–STAT signaling in the immune system , 2017, Nature Immunology.

[19]  V. Kuchroo,et al.  IL-27 Induces Th17 Differentiation in the Absence of STAT1 Signaling , 2015, The Journal of Immunology.

[20]  Simon A. Jones,et al.  Interleukin-27 inhibits ectopic lymphoid-like structure development in early inflammatory arthritis , 2015, The Journal of experimental medicine.

[21]  C. Hunter,et al.  IL-6 as a keystone cytokine in health and disease , 2015, Nature Immunology.

[22]  Elisha D O Roberson,et al.  Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. , 2015, Blood.

[23]  Xiaoming Zhan,et al.  MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses , 2014, Science.

[24]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[25]  D. Stetson,et al.  The enemy within: endogenous retroelements and autoimmune disease , 2014, Nature Immunology.

[26]  David W. Johnson,et al.  Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients , 2014, BMC Nephrology.

[27]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[28]  Howard Y. Chang,et al.  Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position , 2013, Nature Methods.

[29]  B. Jenkins,et al.  Exacerbated inflammatory arthritis in response to hyperactive gp130 signalling is independent of IL-17A , 2013, Annals of the rheumatic diseases.

[30]  T. Wynn,et al.  Cytokine mediated tissue fibrosis. , 2013, Biochimica et biophysica acta.

[31]  D. Miranda-Saavedra,et al.  Genomic and computational approaches to dissect the mechanisms of STAT3’s universal and cell type-specific functions , 2013, JAK-STAT.

[32]  Simon A. Jones,et al.  The problem of choice: current biologic agents and future prospects in RA , 2013, Nature Reviews Rheumatology.

[33]  J. Duffield,et al.  Host responses in tissue repair and fibrosis. , 2013, Annual review of pathology.

[34]  G. Natoli,et al.  Latent Enhancers Activated by Stimulation in Differentiated Cells , 2013, Cell.

[35]  L. French,et al.  Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection. , 2011, The Journal of allergy and clinical immunology.

[36]  J. Scheller,et al.  Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. , 2011, The Journal of clinical investigation.

[37]  A. Fischer,et al.  Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis , 2011, The Journal of experimental medicine.

[38]  C. Fielding,et al.  Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  J. O’Shea,et al.  Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5 , 2011, Nature Immunology.

[40]  G. Natoli,et al.  The genomic landscapes of inflammation. , 2011, Genes & development.

[41]  J. Scheller,et al.  Loss of CD4+ T Cell IL-6R Expression during Inflammation Underlines a Role for IL-6 Trans Signaling in the Local Maintenance of Th17 Cells , 2010, The Journal of Immunology.

[42]  M. Soares,et al.  High-throughput sequence-based epigenomic analysis of Alu repeats in human cerebellum , 2009, Nucleic acids research.

[43]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[44]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[45]  C. Dinarello.  Historical insights into cytokines , 2007, European journal of immunology.

[46]  Eytan Domany,et al.  Alu elements contain many binding sites for transcription factors and may play a role in regulation of developmental processes , 2006, BMC Genomics.

[47]  Simon A. Jones,et al.  Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-61 , 2005, The Journal of Immunology.

[48]  T. Nheu,et al.  Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling , 2005, Nature Medicine.

[49]  C. Fielding,et al.  IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Yulan Qing,et al.  Alternative Activation of STAT1 and STAT3 in Response to Interferon-γ* , 2004, Journal of Biological Chemistry.

[51]  T. S. Wilkinson,et al.  Differential Regulation of Neutrophil-Activating Chemokines by IL-6 and Its Soluble Receptor Isoforms1 , 2004, The Journal of Immunology.

[52]  S. Akira,et al.  Aberrant Inflammation and Lethality to Septic Peritonitis in Mice Lacking STAT3 in Macrophages and Neutrophils 1 , 2003, The Journal of Immunology.

[53]  R. Flavell,et al.  Endothelial Cells Require STAT3 for Protection against Endotoxin-induced Inf lammation , 2003, The Journal of experimental medicine.

[54]  Stefan Rose-John,et al.  Interplay between IFN-γ and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation , 2003 .

[55]  E. Fikrig,et al.  STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: A critical role of STAT3 in innate immunity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Valeria Poli,et al.  Mutational switch of an IL-6 response to an interferon-gamma-like response. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[57]  T. S. Wilkinson,et al.  Differential Regulation of Chemokine Production in Human Peritoneal Mesothelial Cells: IFN-γ Controls Neutrophil Migration Across the Mesothelium In Vitro and In Vivo1 , 2001, The Journal of Immunology.

[58]  T. S. Wilkinson,et al.  Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. , 2001, Immunity.

[59]  Simon A. Jones,et al.  Brief Definitive Report C-reactive Protein: A Physiological Activator of Interleukin 6 Receptor Shedding , 1999 .

[60]  M. Jordana,et al.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. , 1998, The Journal of clinical investigation.

[61]  G. Zimmerman,et al.  Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. , 1997, The Journal of clinical investigation.

[62]  A. Husband,et al.  The role of interleukin-6 in mucosal IgA antibody responses in vivo. , 1994, Science.

[63]  R. Zinkernagel,et al.  Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.

[64]  Lidia Avallea,et al.  STAT1 and STAT3 in tumorigenesis: A matter of balance , 2022 .